The efficiency of POET to treat esophageal submucosal tumor

The efficiency of POET to treat esophageal submucosal tumor - The efficiency of POET to treat esophageal submucosal tumor

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000035061

Enrollment

Registered

2018-11-28

Start date

2018-11-29

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

esophageal submucosal tumor

Interventions

per oral endoscopic tumor resection

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Esophageal submucosal tumor Benign tumor confronting with preoperative biopsy results 2 to 4 cm in size Those with symptoms such as dysphagia Tumor growing tendency

Exclusion criteria

Exclusion criteria: Underage patient Patients who can not obtain their consent Patients taking anticoagulants, antiplatelet drugs, or other internal medications to promote bleeding Other patients judged unsuitable by the attending physician

Design outcomes

Primary

Measure	Time frame
Presence of complications of POET	—

Countries

Japan

Contacts

Public ContactYuusaku Sugihara

Okayama university hospital Department of general medicine

y.sugi117@gmail.com086-235-7219

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026